CMS finalizes drug pricing model tying Medicare Part B rebates to prices in 19 countries, effective Nov. 30, 2026, aiming to reduce U.S. drug costs.
UK Health Secretary Yvette Cooper welcomes AstraZeneca and Daiichi Sankyo’s “life-changing” targeted breast cancer drug ...
Sarah, pictured with Jake, wants a new drug to be made available on the NHS -Credit:Courtesy Sarah Officer / SWNS A desperate mum is campaigning for a new drug to be made available on the NHS that ...
A man who lost his wife to breast cancer has described the drug which could have extended her life finally being made available on the NHS in England as "bittersweet". Fionnuala Quinlan-Bennett, a ...
Enhertu is now available on the NHS in England for eligible women with HER2-low advanced breast cancer after NICE reversed its earlier decision. Women in England with a specific form of advanced ...
Patients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body. Enhertu can give ...
Life-changing breast cancer drug offered to women on NHS in major U-turn – after years-long campaign
A MAJOR U-turn from the NHS spending watchdog means thousands of women with breast cancer will now be able to get a life-extending drug for free. Patients, many of whom spent years campaigning for ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. From reproductive rights to climate change to Big Tech, The Independent is on ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — English health authorities ...
A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed. Enhertu ...
Around 1,000 women annually could benefit from Enhertu, which almost doubles the time patients can live without disease progressing Laura has led award-winning coverage on the NHS, medical science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results